Measured Wealth Private Client Group, LLC Bristol Myers Squibb CO Transaction History
Measured Wealth Private Client Group, LLC
- $307 Million
- Q4 2024
A detailed history of Measured Wealth Private Client Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Measured Wealth Private Client Group, LLC holds 11,164 shares of BMY stock, worth $641,036. This represents 0.21% of its overall portfolio holdings.
Number of Shares
11,164
Previous 5,514
102.47%
Holding current value
$641,036
Previous $285,000
121.4%
% of portfolio
0.21%
Previous 0.1%
Shares
19 transactions
Others Institutions Holding BMY
# of Institutions
2,632Shares Held
1.47BCall Options Held
31.5MPut Options Held
34.9M-
Vanguard Group Inc Valley Forge, PA189MShares$10.8 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.11 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.33 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.47 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.46 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $122B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...